We are pleased to announce the in-license of our oral GLP-1 by Merck, a company with established leadership in cardiometabolic diseases, said Ms
This leaves late-comers Roche, AstraZeneca, Novartis, Pfizer, Amgen and smaller player Viking with a fraction of the market, approximately $20B
10.3390/nu6093460 284
Some ingredients may need to be avoided during specific trimester periods
Wegovy is primarily prescribed for chronic weight management in obese or overweight adults with at least one weight-related condition (e.g., type 2 diabetes, hypertension, high cholesterol)
Here's all you need to know about it (and why it might become 2026's blockbuster drug): Current GLP-1 drugs can cause 35-40% of weight lost to be lean muscle, often worsened by inadequate protein and resistance training